13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001546773
Total reported value
—
—
1 檔
—
During the Q3 2025 filing period, RCF Management L.L.C. (CIK: 0001546773) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at — across 1 reported positions.
In Q3 2025, RCF Management L.L.C. adopted a defensive or profit-taking posture, trimming 0 positions and completely liquidating 1 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology Inc | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IAG | Iamgold CORP | — | EXIT | Sold out |
| 2 | ✓ | Ikena Oncology Inc | — | — | Unchanged |
According to official SEC Form 13F filings, RCF Management L.L.C. reported a total U.S. public equity portfolio value of — across 1 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top Position Liquidated / Trimmed
IAG
前期市值: $102.9M
During Q3 2025, RCF Management L.L.C.'s top holdings by market value included IKENA ONCOLOGY INC (0.0%). The largest single position, IKENA ONCOLOGY INC, represented 0.0% of total portfolio value.
In Q3 2025, RCF Management L.L.C. made 1 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.